Skip to content

The Acute Effects of Interesterification of Commercially Used Fats on Postprandial Lipaemia and Satiety

The Acute Effects of Interesterification of Commercially Used Fats on Postprandial Lipaemia and Satiety: a Randomised Controlled Trial. The INTER-FAT Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02365987
Acronym
INTERFAT
Enrollment
12
Registered
2015-02-19
Start date
2015-02-28
Completion date
2015-12-31
Last updated
2017-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Men

Keywords

interesterified, postprandial

Brief summary

The purpose of this study is to investigate whether there are differences in postprandial metabolic indices following interesterified fats used in commercial spreads versus the corresponding un-interesterified blend.

Detailed description

Aim: The current study aims to investigate the acute effects of commercially relevant interesterified 'hardstock' versus the corresponding un-interesterified blend on postprandial lipaemia, glycaemia, insulinaemia and gut hormone responses. Due to the previously observed differences in gut hormones following interesterified palm oil and un-interesterified palm oil by our group, we will also explore acute effects of these fats on satiety and rates of gastric emptying. Hypothesis: Interesterification of a palm kernel and palm stearin fat blend, to produce a fat with a higher proportion of palmitic acid in the middle position of the TAG (but the same fatty acid composition), will alter postprandial lipid and glucose metabolism. It is also hypothesised that differences in rates of absorption between the test fats will influence gut hormone responses and feelings of satiety. Subjects: Participants will include 10 healthy male volunteers. In order to determine the 'typical' response to the test fats, subjects must not be affected by metabolic syndrome in any way (obesity, dyslipidemia, insulin resistance or hypertension), they must be non-smokers (since smoking influences postprandial lipaemia), and be aged between the ages of 18 and 45 years (since above this age metabolic changes may take place that may affect the way that the body digests and metabolises lipids). Male volunteers have been selected as they elicit a higher postprandial lipaemic response to a given fat load and therefore are more sensitive to dietary manipulation. Power calculation: A sample size of 10 has 80% power to detect a difference between means of 112.74 units in area under the curve in plasma TAG with a significance level (alpha) of 0.05 (two-tailed). Expected value: The study will provide novel information on the acute effects of commercially relevant spreads on postprandial lipaemia and satiety. It will also explore possible mechanisms for the predicted reduced lipaemia following the interesterified fat from measurements of gastric emptying.

Interventions

50g fat provided as interesterified palm kernal and palm sterin blend in a single meal

50g fat provided as un-interesterified palm kernal and palm sterin blend in a single meal

Sponsors

King's College London
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
MALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

1. Age: 18-45 2. Male 3. Healthy (free of diagnosed diseases listed in

Exclusion criteria

) 4. Able to understand the information sheet and willing to comply with study protocol 5. Able to give informed consent

Design outcomes

Primary

MeasureTime frameDescription
Postprandial lipaemia (Postprandial plasma triacylglycerol concentrations)Postprandial 4 hrsPostprandial plasma triacylglycerol concentrations

Secondary

MeasureTime frameDescription
Glycemia (Postprandial plasma glucose and insulin concentrations)Postprandial 4 hrsPostprandial plasma glucose and insulin concentrations
Gut hormones (Postprandial gut peptide YY and glucose-dependent insulinotropic polypeptide concentrations)Postprandial 4 hrsPostprandial gut peptide YY and glucose-dependent insulinotropic polypeptide concentrations

Other

MeasureTime frameDescription
Satiety (Postprandial visual analogue scales)Postprandial 4 hrsPostprandial visual analogue scales
Gastric emptying (Postprandial paracetamol concentrations)Postprandial 4 hrsPostprandial paracetamol concentrations

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026